版本:
中国

BRIEF-Cara Therapeutics announces positive data

April 24 Cara Therapeutics Inc:

* Cara Therapeutics announces positive data from quantitative phase 1 trial measuring respiratory safety of I.V. CR845

* Cara Therapeutics-trial showing that I.V. CR845 did not significantly differ from placebo across 3 quantitative measures of respiratory drive in healthy individuals

* Cara Therapeutics - reported treatment-emergent adverse events were previously reported with CR845 administration; were mild, resolving without intervention Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐